Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

12.0%

3 terminated/withdrawn out of 25 trials

Success Rate

78.6%

-8.0% vs industry average

Late-Stage Pipeline

32%

8 trials in Phase 3/4

Results Transparency

9%

1 of 11 completed trials have results

Key Signals

4 recruiting1 with results

Enrollment Performance

Analytics

Phase 3
7(28.0%)
Phase 1
7(28.0%)
Phase 2
6(24.0%)
N/A
4(16.0%)
Phase 4
1(4.0%)
25Total
Phase 3(7)
Phase 1(7)
Phase 2(6)
N/A(4)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (25)

Showing 20 of 25 trials
NCT07826676Phase 1Not Yet Recruiting

Use of Bone Marrow Stem Cells (MesenCell) for the Treatment of Patients With Chronic Graft-versus-host Disease

Role: collaborator

NCT05814432Phase 3Recruiting

Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS

Role: collaborator

NCT06719947Phase 2Recruiting

HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial

Role: collaborator

NCT07562191Phase 2Recruiting

Inhaled DMT for Major Depressive Disorder

Role: collaborator

NCT06638931Phase 2Recruiting

Agnostic Therapy in Rare Solid Tumors

Role: collaborator

NCT07172724Phase 1Not Yet Recruiting

Clinical Trial to Evaluate the Safety and Immunogenicity of the Vivaxin Vaccine for Malaria Caused by Plasmodium Vivax."

Role: collaborator

NCT07037524Phase 1Not Yet Recruiting

Low Dose Radiotherapy for Heart Failure

Role: collaborator

NCT06970470Not ApplicableNot Yet Recruiting

Efficacy of Spinal Orthoses on Mobility in Older Adults With Hyperkyphosis

Role: collaborator

NCT02691078Phase 2Completed

Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors

Role: collaborator

NCT06783478Phase 2Not Yet Recruiting

NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial

Role: collaborator

NCT02270658Not ApplicableCompleted

Morbidity in Patients With Hypertension and Obstructive Sleep Apnea

Role: collaborator

NCT02532660Phase 3Terminated

Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode

Role: collaborator

NCT04561219Phase 2Completed

Nitazoxanide Therapy for Patients With COVID-19 Pneumonia

Role: collaborator

NCT02056977Not ApplicableUnknown

PEEP Levels Selected by PEEP Titration and PEEP Levels Routinely Used in Post-operative Cardiac Patients With Hypoxemic Respiratory Failure

Role: collaborator

NCT00333827Phase 3Completed

Cell Therapy In Dilated Cardiomyopathy

Role: collaborator

NCT00349271Phase 3Terminated

Cell Therapy in Chagas Cardiomyopathy

Role: collaborator

NCT01154049Phase 1Completed

Study to Evaluate the Safety of the Vaccine Prepared sm14 Against Schistosomiasis

Role: collaborator

NCT02818803Phase 3Completed

Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic

Role: collaborator

NCT02418676Phase 1Completed

Insulin Complexation With Hydroxypropyl-beta-cyclodextrin: Use of the Complex in Gel for Healing of Pressure Ulcers

Role: collaborator

NCT00656721Not ApplicableCompleted

Respiratory Mechanics Effects of Flutter Valve in Bronchiectasis Patients

Role: collaborator